Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 8,762 | 9,799 | 11,358 | 11,346 | 10,508 |
| Gross Profit | 8,762 | 9,799 | 11,358 | 11,346 | 10,508 |
| Operating Expenses | 102,774 | 99,929 | 90,375 | 95,946 | 77,555 |
| Operating Income | -94,012 | -90,130 | -79,017 | -84,600 | -67,047 |
| Other Income | 3,187 | 1,845 | 1,880 | 1,518 | 881 |
| Pre-tax Income | -90,825 | -88,285 | -77,137 | -83,082 | -66,166 |
| Net Income Continuous | -90,825 | -88,285 | -77,137 | -83,082 | -66,166 |
| Net Income | $-90,825 | $-88,285 | $-77,137 | $-83,082 | $-66,166 |
| EPS Basic Total Ops | -1.63 | -1.82 | -1.59 | -1.78 | -1.56 |
| EPS Basic Continuous Ops | -1.63 | -1.82 | -1.59 | -1.78 | -1.56 |
| EPS Diluted Total Ops | -1.63 | -1.82 | -1.59 | -1.78 | -1.56 |
| EPS Diluted Continuous Ops | -1.63 | -1.82 | -1.59 | -1.78 | -1.56 |
| EBITDA(a) | $-92,693 | $-88,512 | $-77,472 | $-83,096 | $-65,293 |